VNRX 8-K 2026-11-12

VOLITIONRX LTD (VNRX) 8-K dated 2026-11-12 — accession 0001477932-26-006845.

VOLITIONRX LTD (VNRX) is a medical devices company listed on AMEX.

VOLITIONRX LTD filed a 8-K on 2026-11-12. Accession 0001477932-26-006845.

This 8-K covers: Director/officer change (Item 5.02). SEC EDGAR holds the official filing and its exhibits.

Latest reported VNRX revenue for 2025-12-31 was $1.7M. Net income was -$23.4M. Revenue was up 40.0% from 2024-12-31 to 2025-12-31. VNRX currently screens at market cap $15.9M.

Not investment advice. The VNRX SEC hub lists recent forms. The stock page is the research view.